Laureano Ana Flávia Santarine, Riboldi Márcia
Universidade Federal do ABC, Centro de Ciências Naturais e Humanas, São Bernardo do Campo - SP.
Igenomix, São Paulo - SP.
JBRA Assist Reprod. 2020 Jul 14;24(3):340-346. doi: 10.5935/1518-0557.20200046.
SARS-CoV-2 is a novel virus from the coronavirus family that emerged in the end of December 2019 in Wuhan, China. The virus is now widespread and causing the current pandemic of COVID-19, a highly pathogenic viral pneumonia, commonly presented with fever and cough, which frequently lead to lower respiratory tract disease with poor clinical outcomes associated with older age and underlying health conditions. Supportive care for patients is typically the standard protocol because no specific effective antiviral therapies have been identified so far. The current outbreak is challenging governments and health authorities all over the world. In here we present a comparison among the current diagnostic tools and kits being used to test Brazilian population.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）是一种来自冠状病毒家族的新型病毒，于2019年12月底在中国武汉出现。该病毒现已广泛传播，导致了当前的新型冠状病毒肺炎（COVID-19）大流行，这是一种高致病性病毒性肺炎，通常表现为发热和咳嗽，常导致下呼吸道疾病，老年患者和有基础健康问题的患者临床预后较差。由于目前尚未确定具体有效的抗病毒疗法，对患者的支持性护理通常是标准方案。当前的疫情给世界各国政府和卫生当局带来了挑战。在此，我们对目前用于检测巴西人群的诊断工具和试剂盒进行比较。
